These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31165232)

  • 1. Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists.
    Auer E; Frey S; Kaesmacher J; Hakim A; Seiffge DJ; Goeldlin M; Arnold M; Fischer U; Jung S; Meinel TR
    J Neurol; 2019 Sep; 266(9):2263-2272. PubMed ID: 31165232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI characteristics in acute ischemic stroke patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists.
    Meinel TR; Kaesmacher J; Gralla J; Seiffge DJ; Auer E; Frey S; El-Koussy M; Arnold M; Fischer U; Göldlin M; Jung S; Hakim A
    BMC Neurol; 2020 Mar; 20(1):86. PubMed ID: 32160909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Ischemic Stroke Outcome and Preceding Anticoagulation: Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Tavares SF; Ferreira I; Chaves V; Flores L; Correia C; Almeida J; Fonseca L; Castro Chaves P
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104691. PubMed ID: 32067853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
    Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
    Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.
    Seiffge DJ; Paciaroni M; Wilson D; Koga M; Macha K; Cappellari M; Schaedelin S; Shakeshaft C; Takagi M; Tsivgoulis G; Bonetti B; Kallmünzer B; Arihiro S; Alberti A; Polymeris AA; Ambler G; Yoshimura S; Venti M; Bonati LH; Muir KW; Yamagami H; Thilemann S; Altavilla R; Peters N; Inoue M; Bobinger T; Agnelli G; Brown MM; Sato S; Acciarresi M; Jager HR; Bovi P; Schwab S; Lyrer P; Caso V; Toyoda K; Werring DJ; Engelter ST; De Marchis GM;
    Ann Neurol; 2019 Jun; 85(6):823-834. PubMed ID: 30980560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
    Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F;
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Inappropriately Dosed Anticoagulation Therapy With Stroke Severity and Outcomes in Patients With Atrial Fibrillation.
    Vinding NE; Butt JH; Olesen JB; Xian Y; Kristensen SL; Rørth R; Bonde AN; Gundlund A; Yafasova A; Weeke PE; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
    J Am Heart Assoc; 2022 Mar; 11(6):e024402. PubMed ID: 35229642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
    Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
    Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of stroke in patients with prior VKA or DOAC: A population-based real-world registry analysis.
    Mayer-Suess L; Rinner H; Lang W; Greisenegger S; Mikšová D; Gattringer T; Enzigner C; Sykora M; Vosko M; Mutzenbach JS; Ferrari J; Kiechl S; Knoflach M;
    Eur Stroke J; 2024 Jun; 9(2):418-423. PubMed ID: 38161290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.
    Meinel TR; Branca M; De Marchis GM; Nedeltchev K; Kahles T; Bonati L; Arnold M; Heldner MR; Jung S; Carrera E; Dirren E; Michel P; Strambo D; Cereda CW; Bianco G; Kägi G; Vehoff J; Katan M; Bolognese M; Backhaus R; Salmen S; Albert S; Medlin F; Berger C; Schelosky L; Renaud S; Niederhauser J; Bonvin C; Schaerer M; Mono ML; Rodic B; Tarnutzer AA; Mordasini P; Gralla J; Kaesmacher J; Engelter S; Fischer U; Seiffge DJ;
    Ann Neurol; 2021 Jan; 89(1):42-53. PubMed ID: 32996627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study.
    Zapata-Wainberg G; Masjuan J; Quintas S; Ximénez-Carrillo Á; García Pastor A; Martínez Zabaleta M; Cardona P; Freijo Guerrero MM; Llull L; Benavente Fernández L; Castellanos Rodrigo M; Egido J; Serena J; Vivancos J;
    Eur J Neurol; 2019 Feb; 26(2):230-237. PubMed ID: 30153363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke/transient ischemic attack patients with non-valvular atrial fibrillation.
    Tomari S; Arima J; Yoshida T; Yamashita H; Sata R; Hamada R; Kanda N; Takashima H
    J Neurol Sci; 2019 Jul; 402():162-166. PubMed ID: 31152970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.
    Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W
    Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission Severity of Atrial-Fibrillation-Related Acute Ischemic Stroke in Patients under Anticoagulation Treatment: A Systematic Review and Meta-Analysis.
    Garcia C; Silva M; Araújo M; Henriques M; Margarido M; Vicente P; Nzwalo H; Macedo A
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events.
    Seiffge DJ; Traenka C; Polymeris A; Hert L; Peters N; Lyrer P; Engelter ST; Bonati LH; De Marchis GM
    Neurology; 2016 Nov; 87(18):1856-1862. PubMed ID: 27694266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
    Ha FJ; Barra S; Brown AJ; Begley DA; Grace AA; Agarwal S
    Int J Cardiol; 2018 Jul; 262():51-56. PubMed ID: 29606512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients.
    Meinel TR; Kniepert JU; Seiffge DJ; Gralla J; Jung S; Auer E; Frey S; Goeldlin M; Mordasini P; Mosimann PJ; Nogueira RG; Haussen DC; Rodrigues GM; Uphaus T; L'Allinec V; Krajíčková D; Alonso A; Costalat V; Hajdu SD; Olivé-Gadea M; Maegerlein C; Pierot L; Schaafsma J; Suzuki K; Arnold M; Heldner MR; Fischer U; Kaesmacher J
    Stroke; 2020 Mar; 51(3):892-898. PubMed ID: 31992179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.